# Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/vedolizumab-dose-escalation-improves-therapeutic-response-in-a-subset-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Courtney Perry,Kyle B. Fischer,Ahmed Elmoursi,Cody Kern,Alden Currier,Praneeth Kudaravalli,Olalekan Akanbi,Nishant Tripathi,Pradeep Yarra,Leon Su,Deborah Flomenhoft,Arnold J. Stromberg,Terrence A. Barrett |
| Citations | 29 |
| DOI | 10.1007/s10620-020-06486-x |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3045459599 |
| PMID | 32710192 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Praneeth Kudaravalli](https://scholariq.org/researchers/praneeth-kudaravalli/)

## Paper journal

- [Digestive Diseases and Sciences](https://scholariq.org/journals/digestive-diseases-and-sciences/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.